TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial.

Thomas Denize et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.